Publication | Closed Access

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

Gastrointestinal OncologyMedicineInfusional 5-Fluorouracil/folinic AcidPharmacologyColorectal CancerMetastatic Colorectal CancerFirst-line TreatmentPharmacotherapyCancer TreatmentOncologyCancer Research